Commercial Manager, Mendelian

£45-55k

Commission

Senior level
London
Mendelian

Accelerates diagnoses of rare diseases

Job no longer available

Mendelian

Accelerates diagnoses of rare diseases

21-100 employees

HealthcareB2BArtificial IntelligenceBig dataSaaS

Job no longer available

£45-55k

Commission

Senior level
London

21-100 employees

HealthcareB2BArtificial IntelligenceBig dataSaaS

Company mission

We’re helping to end the diagnostic odyssey by bringing timely patient insights to primary care.

Role

Who you are

  • 5+ years of sales experience with pharma as client - ideally selling a clinically-oriented or tech product
  • Existing relationships and contacts in pharma industry (Executive, Commercial, Medical Affairs, and R&D)
  • Demonstrated success in building substantial commercial pipeline and driving revenue growth
  • Experience of working in a fast-pace technology startup environment
  • Good working knowledge of healthcare markets and their challenges (including healthcare systems, pharma companies, regulations, data privacy)
  • Curious, confident, creative, competitive
  • An excellent communicator and networker
  • Detail-oriented and organised
  • Motivated to set an ambitious goal and achieve it!

What the job involves

  • Build sales pipeline and deliver revenue growth
  • Tailor sales collateral (including pitch decks and proposals)
  • Own end-to-end deal execution
  • Support project delivery and grow client relationships
  • Maintain CRM and support finance and billing
  • Collaborate cross-functionally to inform product roadmap, value propositions, and product-market fit

Salary benchmarks

Share this job

Insights

Led by a woman
Top investors

22% female employees

Company

Company benefits

  • Pet-friendly office
  • Work from home opportunities
  • Meaningful equity package

Funding (last 2 of 5 rounds)

Mar 2023

$1.9m

GRANT

Feb 2022

$0.5m

GRANT

Total funding: $4.1m

Our take

Rare diseases affect over 350 million patients worldwide. Unfortunately, it can take years of research and misdiagnoses before the correct rare disease is identified. This so-called "diagnostic odyssey" is not only causing patients distress and emotional turmoil, but also frustration among clinicians and an enormous financial burden on healthcare systems and associated trusts. This is the problem that Mendelian has set out to overturn.

Mendelian’s specialised screening system, dubbed MendelScreen, incorporates augmented intelligence and data analysis to produce a ranked list of likely causative disease genes based on how closely the patient’s query matches a disease. The company's platform is even more unique as it goes one step further to make "smart suggestions” regarding diagnosis, specialist referral and recommendations for further tests and analysis.

Mendelian's ultimate goal is to provide timely diagnoses for every patient suffering from a rare disease. It continually invests into its service to ensure the reports it provides are optimised for efficiency and data provision.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle